CrushSCI reveals real review times for each journal, giving authors transparent guidance for submission. As AI makes publishing increasingly challenging, the platform helps authors improve submission efficiency. Contact us if you need assistance.
Medicine
Medicine
Back to journal directory
Review Cycle Records
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
Paper Review Records
All Paper Review Records
4 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
134
days
Nitric Oxide–cGMP Pathway Modulation in an Experimental Model of Hypoxic Pulmonary Hypertension
Authors
Melanie Reinero; Maurice Beghetti; Piergiorgio Tozzi; Ludwig K. von Segesser; Michele Samaja; Giuseppina MilanoShow moreShow less
Affiliations
1. Department Cœur-Vaisseaux, Cardiac Surgery Center, University Hospital of Lausanne, Lausanne, Switzerland; 2. Unité de Cardiologie Pédiatrique, 30538University Hospital of Geneva and Centre Universitaire Romand de Cardiologie et Chirurgie Cardiaque Pédiatrique University of Geneva and Lausanne, Switzerland; 3. Department of Surgery and Anesthesiology, Cardio-Vascular Research, Lausanne, Switzerland; 4. Department of Health Science, 9304University of Milano, Milan, ItalyShow moreShow less
11
days
Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study
Authors
Hakeam A. Hakeam; Muhannad Alsemari; Zainab Al Duhailib; Leen Ghonem; Saad A. Alharbi; Eid Almutairy; Nader M. Bin Sheraim; Meshal Alsalhi; Ali Alhijji; Sara AlQahtani; Mohammed Khalid; Mazin BarryShow moreShow less
Affiliations
1. Pharmaceutical Care, 37852King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; 2. College of Medicine, Alfaisal University, Riyadh, Saudi Arabia; 3. Department of Surgery, 37852King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; 4. Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; 5. Critical Care Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; 6. Department of Pharmacy, Clinical Pharmacy Services, 534884King Saud University Medical City, Riyadh, Saudi Arabia; 7. Pharmacy Services, Buriadh Central Hospital, Buriadh, Saudi Arabia; 8. Pulmonary Medicine, 37852King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia; 9. Pharmacy Service, 430300King Abdullah Bin Abdulaziz University Hospital, Riyadh, Saudi Arabia; 10. Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, 191082King Saud University, Saudi ArabiaShow moreShow less
51
days
Hemodynamic Effects of a Soluble Guanylate Cyclase Stimulator, Riociguat, and an Activator, Cinaciguat, During NO-Modulation in Healthy Pigs
Authors
Torvind Næsheim; Ole-Jakob How; Truls MyrmelShow moreShow less
Affiliations
1. Department of Clinical Medicine, Cardiovascular Research Groups, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway; 2. Department of Anaesthesiology, University Hospital of North Norway, Tromsø, Norway; 3. Department of Medical Biology, Cardiovascular Research Groups, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway; 4. Department of Cardiothoracic and Vascular Surgery, Heart and Lung Clinic, University Hospital of North Norway, Tromsø, NorwayShow moreShow less
4
days
Evaluation of the Switch From Amiodarone to Dronedarone in Patients With Atrial Fibrillation: Results of the ARTEMIS AF Studies
Authors
Gerald V. Naccarelli; Deepak L. Bhatt; A. John Camm; Jean-Yves Le Heuzey; Federico Lombardi; Juan Tamargo; Jean-Marie Martinez; Lisa Naditch-Brûlé; for the ARTEMIS AF InvestigatorsShow moreShow less
Affiliations
1. Division of Cardiology, Heart and Vascular Institute, Penn State University College of Medicine, Hershey, PA, USA; 2. Brigham and Women’s Hospital Heart & Vascular Center and Harvard Medical School, Boston, MA, USA; 3. Cardiology Clinical Academic Group Molecular & Clinical Sciences Institute, St George’s University of London, London, UK; 4. Hôpital Européen Georges Pompidou, Université Paris V René Descartes, Paris, France; 5. Cardiologia, Fondazione IRCCS Ospedale Maggiore Policlinico, Milan, Italy; 6. Department of Clinical Science and Health Community, University of Milan, Milan, Italy; 7. Department of Pharmacology and Toxicology, School of Medicine, CIBERCV, University Complutense, Madrid, Spain; 8. Sanofi, Montpellier, France; 9. Sanofi, Paris, FranceShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days